最低剂量白细胞介素-2免疫疗法。 - Suppr

Suppr

超能文献

Lowest dose interleukin-2 immunotherapy.

作者信息

Smith K A

机构信息

Department of Medicine, Dartmouth Medical School, Hanover, NH 03755-3833.

出版信息

Blood. 1993 Mar 15;81(6):1414-23.

PMID:8453090

Abstract

摘要

相似文献

Lowest dose interleukin-2 immunotherapy.最低剂量白细胞介素-2免疫疗法。

Blood. 1993 Mar 15;81(6):1414-23.

[Biological properties and therapeutic use of interleukin 2 (IL-2)].

Postepy Hig Med Dosw. 1995;49(3):367-93.

Rational immunotherapy with interleukin 2.

Biotechnology (N Y). 1992 Feb;10(2):157-62. doi: 10.1038/nbt0292-157.

Human interleukin 2: molecular biology, physiology and clinical possibilities.人白细胞介素2：分子生物学、生理学及临床应用前景

Immunobiology. 1986 Sep;172(3-5):400-19. doi: 10.1016/S0171-2985(86)80121-8.

Human interleukin 2: biochemistry, physiology, and possible pathogenetic role in immunodeficiency syndromes.

Cancer Invest. 1985;3(1):35-49. doi: 10.3109/07357908509040606.

IL-15 in the life and death of lymphocytes: immunotherapeutic implications.白细胞介素-15在淋巴细胞生死过程中的作用：免疫治疗意义

Trends Mol Med. 2003 Dec;9(12):517-21. doi: 10.1016/j.molmed.2003.10.005.

The biological basis for interleukin-2 anticancer therapy.

Prog Clin Biol Res. 1990;354B:37-52.

Interleukin 2 in cancer therapy.白细胞介素2在癌症治疗中的应用。

Ann Ist Super Sanita. 1990;26(3-4):283-334.

Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation.自体骨髓移植后大剂量白细胞介素-2治疗神经母细胞瘤残留病一年期间自然免疫的进展

Exp Hematol. 1995 Dec;23(14):1445-52.

Effects of escalating doses of recombinant human interleukin-2 in correcting functional T-cell defects following autologous bone marrow transplantation for lymphomas and solid tumors.递增剂量重组人白细胞介素-2对淋巴瘤和实体瘤自体骨髓移植后纠正功能性T细胞缺陷的作用。

Exp Hematol. 1992 Sep;20(8):962-8.

引用本文的文献

Harnessing CD8 T cell responses using PD-1-IL-2 combination therapy.利用 PD-1-IL-2 联合疗法激发 CD8 T 细胞应答。

Trends Cancer. 2024 Apr;10(4):332-346. doi: 10.1016/j.trecan.2023.11.008. Epub 2023 Dec 20.

Do Bacteria Provide an Alternative to Cancer Treatment and What Role Does Lactic Acid Bacteria Play?细菌能否为癌症治疗提供替代方案，乳酸菌又发挥着怎样的作用？

Microorganisms. 2022 Aug 27;10(9):1733. doi: 10.3390/microorganisms10091733.

Angiogenesis Inhibitors and Immunomodulation in Renal Cell Cancers: The Past, Present, and Future.肾细胞癌中的血管生成抑制剂与免疫调节：过去、现在与未来

Cancers (Basel). 2022 Mar 9;14(6):1406. doi: 10.3390/cancers14061406.

Engineering Strategies for Immunomodulatory Cytokine Therapies - Challenges and Clinical Progress.免疫调节细胞因子疗法的工程策略——挑战与临床进展

Adv Ther (Weinh). 2021 Aug;4(8). doi: 10.1002/adtp.202100035. Epub 2021 Apr 2.

Therapeutic Efficacy of Delta-Like Ligand 4 Gene Vaccine Overexpression on Liver Cancer in Mice.Delta 样配体 4 基因疫苗过表达对小鼠肝癌的治疗效果。

Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820942205. doi: 10.1177/1533033820942205.

Pharmacokinetics of inhaled nanotherapeutics for pulmonary delivery.用于肺部给药的吸入纳米治疗药物的药代动力学

J Control Release. 2020 Oct 10;326:222-244. doi: 10.1016/j.jconrel.2020.07.011. Epub 2020 Jul 16.

Oscillatory IL-2 stimulus reveals pertinent signaling timescales of T cell responsiveness.振荡的 IL-2 刺激揭示了 T 细胞响应的相关信号时间尺度。

PLoS One. 2018 Sep 18;13(9):e0203759. doi: 10.1371/journal.pone.0203759. eCollection 2018.

Prostate-specific membrane antigen-based therapeutics.基于前列腺特异性膜抗原的疗法。

Adv Urol. 2012;2012:973820. doi: 10.1155/2012/973820. Epub 2011 Jul 17.

Attenuated Salmonella typhimurium with IL-2 gene reduces pulmonary metastases in murine osteosarcoma.携带白细胞介素-2基因的减毒鼠伤寒沙门氏菌可减少小鼠骨肉瘤的肺转移。

Clin Orthop Relat Res. 2008 Jun;466(6):1285-91. doi: 10.1007/s11999-008-0243-2. Epub 2008 Apr 18.

Role of common gamma chain utilizing cytokines for immune reconstitution in HIV infection.利用共同γ链细胞因子在HIV感染中进行免疫重建的作用。

Immunol Res. 2007;38(1-3):373-86. doi: 10.1007/s12026-007-0036-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验